Maximize Market Research's latest report, " Global Remdesivir Market Global Demand Analysis and Opportunity Outlook 2027", offers a comprehensive analysis of the market. It provides market segments by type and shape, as well as end-user industries and regions.
Global Remdesivir Market size was valued at US$ XX Mn in 2019 and the total revenue is expected to grow at 8.0% through 2020 to 2026, reaching nearly US$ XX Mn.
Global Remdesivir Market Overview
Remdesivir is an antiviral drug being used for the treatment of coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus. Remdesivir is a prodrug of a nucleotide analog that is intracellularly digested to an analog of adenosine triphosphate and inhibits viral RNA polymerases. Remdesivir has not experienced the standard review to be approved by the FDA for use.
Though, the FDA has permitted an Emergency Use Authorization (EUA) to allow adults and children who are hospitalized with severe COVID-19 to receive Remdesivir. Remdesivir has broad-spectrum antiviral activity both in vitro and in vivo in animal models against multiple developing viral pathogens, like Ebola, SARS, Marburg, MERS, and SARS-CoV-2; the virus that causes COVID-19.
Get a Sample PDF of the Report at : Request Free Sample Report
Global Remdesivir Market Major Market Players
• Gilead Sciences, Inc.
• BrightGene Bio-Medical Technology Co.,Ltd.
• Hainan Haiyao Co., Ltd.
• EVA PHARM
• Cipla Inc.
• Mylan N.V.
• Ferozsons Laboratories.
• Zydus Cadila.
• Dr. Reddy’s Laboratories Ltd.
• Beximco Pharmaceuticals Ltd.
The Market Impact of COVID-19
The COVID-19 epidemic has quickly spreaded since its inception in Wuhan (China), in December 2019.
All around the globe. As of March 2020, the US and China were the most affected. The COVID-19 crisis has had a significant impact on many countries, resulting in travel bans or lockdowns. Industries. This outbreak has severely affected the global food and beverage industries.
This includes office closures, cancellations of technology events, and supply chain disruptions. China is the world's largest manufacturing country and has the largest number of raw material suppliers. COVID-19 has an adverse effect on overall production because it closes factories and creates supply chain challenges. Market growth.
Segmentation of Global Remdesivir Market by Types and Applications:
The report has covered the market size by country (regions) for the global Remdesivir market. Segment by Application. The Remdesivir Market is divided into the North America Europe, ASIA Pacific, Middle East Africa. The report also includes market size estimates by region. 2019-2027 Forecasts and market size for each type and segment are included. Sales and revenue are included for the period 2019-2027.
Analysis of the Remdesivir Market Share and Competitive Landscape:
This report provides a detailed analysis of the Global Remdesivir Market for all stakeholders. . It also contains historical and forecasted market size information. Trends are also included in the report. The report is simple and simplifies complicated data using simple language. This report includes information on all aspects of the industry, as well as key players like market leaders, followers and new entrants. The report includes a PORTER, SVOR and a PESTEL analysis. The report also analyzes the potential market impact of microeconomic variables. This report examines both internal and external factors that can have a positive or negative effect on the business. This report will provide a clear view of the industry for decision-makers.
More about us:
Maximize Market Research has been a trusted partner for many prestigious clients including Yamaha, Sensata and Etnyre in Canada, ALCOR MA Microsoft and Harman. Maximize Market Research offers market research to both B2B and C2C regarding 5000 emerging technologies potentials in Transportation, Chemical and Healthcare, Electronics Communications, and Pharmaceuticals.
Maximize Market Research Pvt ltd